North America Medical Perfusion Technology Market to Grow at a CAGR of 4.4% to reach US$ 403.8 million from 2020 to 2027

North America Medical Perfusion Technology Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technique (Hypothermic Machine Perfusion and Normothermic Machine Perfusion), Organ Type (Heart, Lung, Kidney, Liver, and Others); Component (Perfusion Pumps, Oxygenators, Heart-Lung Machines, Monitoring Systems, Cannulas, and Others)

  • Report Code : TIPRE00021075
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 120
Buy Now

The North America medical perfusion technology market is expected to reach US$ 403.8 million in 2027 from US$ 288.2 million in 2019. The market is estimated to grow with a CAGR of 4.4% from 2020-2027.

Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissue, or volume of blood per unit time (blood flow) per unit tissue mass. During major surgery, perfusion must be maintained and managed by the health professionals involved, rather than left to the body's homeostasis alone. The scope of the medical perfusion technology market includes technique, organ type, component, and region.

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

NORTH AMERICA MEDICAL PERFUSION TECHNOLOGY MARKET SEGMENTATION

By Technique

  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion

By Organ Type

  • Heart
  • Lung
  • Kidney
  • Liver
  • Others

By Component

  • Perfusion Pumps
  • Oxygenators
  • Heart-Lung Machines
  • Monitoring Systems
  • Cannulas
  • Others

By Country

  • North America
  • US
  • Canada
  • Mexico

Company Profiles

  • Medtronic
  • LivaNova PLC
  • Terumo Corporation
  • XVIVO Perfusion
  • OrganOx Limited
  • Waters Medical Systems LLC
  • TransMedics
  • Organ Recovery Systems
  • Xenios AG - a Fresenius Medical Care company

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Technique, Organ Type, Component

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Medical Perfusion Technology Market – By Technique

1.3.2 Medical Perfusion Technology Market – By Organ Type

1.3.3 Medical Perfusion Technology Market – By Component

1.3.4 North America Medical Perfusion Technology Market – By Country

2. North America Medical Perfusion Technology Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Medical Perfusion Technology Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Medical Perfusion Technology Market- North America PEST Analysis

4.3 Expert Opinion

5. North America Medical Perfusion Technology Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Cardiovascular Conditions

5.1.2 Increasing Practice of Organ Transplantation

5.2 Market Restraints

5.2.1 Expensive Organ Transplant Surgeries

5.3 Market Opportunities

5.3.1 Growth Opportunities in Emerging Nations

5.4 Future Trends

5.4.1 Perfusion Instruments for Cell-based Research Activities

5.5 Impact Analysis

6. Medical Perfusion Technology Market – North America Analysis

6.1 North America Medical Perfusion Technology Market Revenue Forecasts and Analysis

7. North America Medical Perfusion Technology Market Analysis and Forecasts To 2027 – By Technique

7.1 Overview

7.2 Medical Perfusion Technology Market Share, by Technique, 2019 and 2027 (%)

7.3 Hypothermic Machine Perfusion

7.3.1 Overview

7.3.2 Hypothermic Machine Perfusion: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (US$ Million)

7.4 Normothermic Machine Perfusion

7.4.1 Overview

7.4.2 Normothermic Machine Perfusion: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (US$ Million)

8. North America Medical Perfusion Technology Market Analysis and Forecasts To 2027– By Organ Type

8.1 Overview

8.2 Medical Perfusion Technology Market Share, by Organ Type, 2019 and 2027 (%)

8.3 Heart

8.3.1 Overview

8.3.2 Heart: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (USD Million)

8.4 Lung

8.4.1 Overview

8.4.2 Lung: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (USD Million)

8.5 Kidney

8.5.1 Overview

8.5.2 Kidney: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (USD Million)

8.6 Liver

8.6.1 Overview

8.6.2 Liver: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (USD Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (USD Million)

9. North America Medical Perfusion Technology Market Analysis and Forecasts To 2027– By Component

9.1 Overview

9.2 Medical Perfusion Technology Market, By Component 2019 & 2027 (%)

9.3 Perfusion Pumps Market

9.3.1 Overview

9.3.2 Perfusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)

9.4 Oxygenators market

9.4.1 Overview

9.4.2 Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)

9.5 Heart Lung Machine Market

9.5.1 Overview

9.5.2 Heart-Lung Machine Market Revenue and Forecasts to 2027 (US$ Mn)

9.6 Monitoring Systems market

9.6.1 Overview

9.6.2 Monitoring Systems Market Revenue and Forecasts to 2027 (US$ Mn)

9.7 Cannulas Market

9.7.1 Overview

9.7.2 Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)

9.8 Others

9.8.1 Overview

9.8.2 Others Market Revenue and Forecasts to 2027 (US$ Mn)

10. Medical Perfusion Technology Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1 North America: Medical Perfusion Technology Market

10.1.1 Overview

10.1.2 North America: Medical Perfusion Technology Market, by Country, 2019& 2027 (%)

10.1.2.1 US: Medical Perfusion Technology Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.1.1 US: Medical Perfusion Technology Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.1.2 US: Medical Perfusion Technology Market, by Technique, 2018–2027 (USD Million)

10.1.2.1.3 US: Medical Perfusion Technology Market, by Organ Type, 2018–2027 (USD Million)

10.1.2.1.4 US: Medical Perfusion Technology Market, by Component, 2018–2027 (USD Million)

10.1.2.2 Canada: Medical Perfusion Technology Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.2.1 Canada: Medical Perfusion Technology Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.2.2 Canada: Medical Perfusion Technology Market, by Technique, 2018–2027 (USD Million)

10.1.2.2.3 Canada: Medical Perfusion Technology Market, by Organ Type, 2018–2027 (USD Million)

10.1.2.2.4 Canada: Medical Perfusion Technology Market, by Component, 2018–2027 (USD Million)

10.1.2.3 Mexico: Medical Perfusion Technology Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.3.1 Mexico: Medical Perfusion Technology Market – Revenue and Forecast to 2027 (USD Million)

10.1.2.3.2 Mexico Medical Perfusion Technology Market, by Technique – Revenue and Forecast to 2027 (USD Million)

10.1.2.3.3 Mexico Medical Perfusion Technology Market, by Organ Type – Revenue and Forecast to 2027 (USD Million)

10.1.2.3.4 Mexico Medical Perfusion Technology Market, by Component – Revenue and Forecast to 2027 (USD Million)

11. Impact Of COVID-19 Pandemic on North America Medical Perfusion Technology Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

12. Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. COMPANY PROFILES

13.1 Medtronic

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 LivaNova PLC

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Terumo Corporation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 XVIVO Perfusion

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 OrganOx Limited

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Waters Medical Systems LLC

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 TransMedics

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Organ Recovery Systems

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Xenios AG - a Fresenius Medical Care company

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. US Medical Perfusion Technology Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 2. US Medical Perfusion Technology Market, by Organ Type– Revenue and Forecast to 2027 (USD Million)

Table 3. US Medical Perfusion Technology Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 4. Canada Medical Perfusion Technology Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 5. Canada Medical Perfusion Technology Market, by Organ Type– Revenue and Forecast to 2027 (USD Million)

Table 6. Canada Medical Perfusion Technology Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 7. Mexico Medical Perfusion Technology Market, by Technique – Revenue and Forecast to 2027 (USD Million)

Table 8. Mexico Medical Perfusion Technology Market, by Organ Type – Revenue and Forecast to 2027 (USD Million)

Table 9. Mexico Medical Perfusion Technology Market, by Component – Revenue and Forecast to 2027 (USD Million)

Table 10. organic Developments Done by Companies

Table 11. Inorganic Developments Done by Companies

Table 12. Glossary of Terms, Medical Perfusion Technology Market

LIST OF FIGURES

Figure 1. Medical Perfusion Technology Market Segmentation

Figure 2. North America Medical Perfusion Technology Market Overview

Figure 3. Hypothermic Machine Perfusion Segment Held Largest Share of Technique in Medical Perfusion Technology Market

Figure 4. Kidney Segment Held Largest Share of Organ Type in Medical Perfusion Technology Market

Figure 5. US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Medical Perfusion Technology Market - North America PEST Analysis

Figure 7. Medical Perfusion Technology Market Impact Analysis of Driver and Restraints

Figure 8. North America Medical Perfusion Technology Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9. Medical Perfusion Technology Market Share, by Technique, 2019 and 2027 (%)

Figure 10. Hypothermic Machine Perfusion: Medical Perfusion Technology Market– Revenue and Forecast to 2027(US$ Million)

Figure 11. Normothermic Machine Perfusion: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (US$ Million)

Figure 12. Medical Perfusion Technology Market Share, by Organ Type, 2019 and 2027 (%)

Figure 13. Heart: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (USD Million)

Figure 14. Lung: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (USD Million)

Figure 15. Kidney: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (USD Million)

Figure 16. Liver: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (USD Million)

Figure 17. Others: Medical Perfusion Technology Market– Revenue and Forecast to 2027 (USD Million)

Figure 18. Medical Perfusion Technology Market, By Component 2019 & 2027 (%)

Figure 19. Perfusion Pumps Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20. Oxygenators Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21. Heart-Lung Machine Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22. Monitoring Systems Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23. Cannulas Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 24. Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25. North America: Medical Perfusion Technology Market, by Key Country – Revenue (2019) (USD Million)

Figure 26. North America: Medical Perfusion Technology Market, by Country, 2019 & 2027 (%)

Figure 27. US: Medical Perfusion Technology Market – Revenue and Forecast to 2027 (USD Million)

Figure 28. Canada: Medical Perfusion Technology Market – Revenue and Forecast to 2027 (USD Million)

Figure 29. Mexico: Medical Perfusion Technology Market – Revenue and Forecast to 2027 (USD Million)

Figure 30. Impact of COVID-19 Pandemic in North American Country Markets

Figure 31. Growth Strategies Done by the Companies in the Market, (%)

  1. Medtronic
  2. LivaNova PLC
  3. Terumo Corporation
  4. XVIVO Perfusion
  5. OrganOx Limited
  6. Waters Medical Systems LLC
  7. TransMedics
  8. Organ Recovery Systems
  9. Xenios AG - a Fresenius Medical Care company

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to North America Medical Perfusion Technology Market